T1	Participants 40 74	children and young adults with HIV
T2	Participants 172 193	HIV-infected patients
T3	Participants 452 473	HIV-infected subjects
T4	Participants 516 636	perinatally acquired HIV (PHIV)-infected subjects or behaviorally acquired HIV (BHIV)-infected subjects (5.0-24.9 years)
T5	Participants 746 821	Fifty-eight subjects enrolled (67% male, 85% African American and 64% BHIV)
